These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1560110)

  • 1. Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo.
    Ransohoff RM; Tuohy VK; Barna BP; Rudick RA
    J Neuroimmunol; 1992 Apr; 37(3):169-76. PubMed ID: 1560110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II major histocompatibility complex antigen expression on unstimulated and gamma-interferon stimulated monocytes from patients with multiple sclerosis, rheumatoid arthritis and normal controls.
    Armstrong MA; Crockard AD; Hawkins SA; Gamble LA; Shah S; Bell AL
    Autoimmunity; 1991; 9(3):261-8. PubMed ID: 1777559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes.
    Crockard AD; Treacy MT; Droogan AG; Hawkins SA
    J Neuroimmunol; 1996 Oct; 70(1):29-35. PubMed ID: 8862132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis.
    Baxevanis CN; Reclos GJ; Arsenis P; Anastasopoulos E; Katsiyiannis A; Lymberi P; Matikas N; Papamichail M
    J Neuroimmunol; 1989 May; 22(3):177-83. PubMed ID: 2649510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothymosin-alpha enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosis.
    Baxevanis CN; Sfagos C; Anastasopoulos E; Reclos GJ; Papamichail M
    J Neuroimmunol; 1990 May; 27(2-3):141-7. PubMed ID: 2139665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in chronic inflammatory arthritis. III. Rheumatoid arthritis monocytes are not unusually sensitive to gamma-interferon, but have defective gamma-interferon-mediated HLA-DQ and HLA-DR induction.
    Bergroth V; Zvaifler NJ; Firestein GS
    Arthritis Rheum; 1989 Sep; 32(9):1074-9. PubMed ID: 2505778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
    Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
    J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production.
    Livingston DH; Loder PA; Kramer SM; Gibson UE; Polk HC
    Arch Surg; 1994 Feb; 129(2):172-8. PubMed ID: 7905730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes.
    Soilu-Hänninen M; Salmi A; Salonen R
    J Neuroimmunol; 1995 Jul; 60(1-2):99-106. PubMed ID: 7642754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of monocyte 5'nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases.
    Armstrong MA; Shah S; Hawkins SA; Bell AL; Roberts SD
    Ann Neurol; 1988 Jul; 24(1):12-6. PubMed ID: 2843076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients.
    Hershman MJ; Appel SH; Wellhausen SR; Sonnenfeld G; Polk HC
    Clin Exp Immunol; 1989 Jul; 77(1):67-70. PubMed ID: 2504520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of HLA-DR antigen expression by human monocytes during cultivation in absence of exogenous or endogenous interferon-gamma.
    Volk HD; Waschke SR; Diezel W; Grunow R; von Baehr R; Fiebig H
    Immunol Lett; 1985; 10(2):103-7. PubMed ID: 3928486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.
    Heagy W; Kelley VE; Strom TB; Mayer K; Shapiro HM; Mandel R; Finberg R
    J Clin Invest; 1984 Dec; 74(6):2089-96. PubMed ID: 6439741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.